Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey M. Leiden currently holds 34,797 shares of VERTEX PHARMACEUTICALS INC / MA (VRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey M. Leiden has been a net seller of VRTX stock. They have purchased $100.1K and sold $545.0M worth of shares.
Jeffrey M. Leiden's most recent insider trade was on Feb 24, 2026, when they sold 3,547 shares at $485.11 per share.
Jeffrey M. Leiden serves as Executive at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have executed 311 insider transactions totaling $545.1M over their tenure at the company.
Jeffrey M. Leiden holds the position of Executive at VERTEX PHARMACEUTICALS INC / MA, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Jeffrey M. Leiden has shown a selling trading pattern, with $100.1K in total purchases and $545.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jeffrey M. Leiden was on Nov 14, 2025, when they sold $14.2M worth of VRTX shares. This transaction involved 32,234 shares at $440.30 per share.
Jeffrey M. Leiden currently owns 34,797 shares of VERTEX PHARMACEUTICALS INC / MA (VRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey M. Leiden's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey M. Leiden has 311 Form 4 filings on record as an insider at VERTEX PHARMACEUTICALS INC / MA.
Set alerts for Jeffrey M. Leiden and 40,000+ other insiders.